This Women’s Healthcare Stock Has Gone From Mistake To Contrarian Opportunity
The author of today’s article made a mistake when they previously went against their rules for trading a premium-priced biotech and jumped on a small-cap…
Pharma Stocks
Why This Seemingly ‘Great Deal’ Pharma Stock Is Contraindicated
With a massive cash balance (and no debt), rapidly growing revenue and earnings, and a well-stocked pipeline, the pharma stock that’s the focus of today’s…
This “Heads We Win, Tails We Still Win” Pharmaceutical Distributor Stock Is “Incredibly Cheap”
In regards to the stock of this high-quality pharmaceutical distributor, the author of today’s article declares that it “is not just cheap – it’s incredibly…
3 Big Pharma Buy-And-Holds
When it comes to identifying stocks that you can buy and hold for years, the author of today’s article points to three important criteria: attractive…
Stocks To Cash In On The $35 Billion NASH Dash
Non-alcoholic steatohepatitis (NASH) is expected to become the leading cause of all liver transplants by 2020 – and there is currently no approved treatment for…
The 21st Century Cures Act: How Investors Can Profit From This Potential “Boon For Big Pharma”
Today’s article notes that it takes almost $1 billion to bring a new drug to market, stifling competition and allowing drug companies to charge Americans…